ALX Oncology
ALXO
ALXO
87 hedge funds and large institutions have $410M invested in ALX Oncology in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 32 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
12% less funds holding
Funds holding: 99 → 87 (-12)
34% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 32
61% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 18
Holders
87
Holding in Top 10
2
Calls
$252K
Puts
$27K
Top Buyers
| 1 | +$16.7M | |
| 2 | +$2.04M | |
| 3 | +$1.01M | |
| 4 |
BlackRock
New York
|
+$346K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$214K |
Top Sellers
| 1 | -$7.01M | |
| 2 | -$3.35M | |
| 3 | -$1.63M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$1.63M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.13M |